000 01336 a2200349 4500
005 20250513223914.0
264 0 _c20031021
008 200310s 0 0 eng d
022 _a1522-8037
024 7 _a10.1007/s11894-000-0013-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThomson, A B
245 0 0 _aAre the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole.
_h[electronic resource]
260 _bCurrent gastroenterology reports
_cDec 2000
300 _a482-93 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Review
650 0 4 _a2-Pyridinylmethylsulfinylbenzimidazoles
650 0 4 _aAnti-Ulcer Agents
_xpharmacology
650 0 4 _aBenzimidazoles
_xpharmacology
650 0 4 _aDrug Interactions
650 0 4 _aDuodenal Ulcer
_xdrug therapy
650 0 4 _aGastroesophageal Reflux
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLansoprazole
650 0 4 _aOmeprazole
_xanalogs & derivatives
650 0 4 _aPantoprazole
650 0 4 _aProton Pump Inhibitors
650 0 4 _aRabeprazole
650 0 4 _aSulfoxides
_xpharmacology
773 0 _tCurrent gastroenterology reports
_gvol. 2
_gno. 6
_gp. 482-93
856 4 0 _uhttps://doi.org/10.1007/s11894-000-0013-0
_zAvailable from publisher's website
999 _c11020757
_d11020757